ライフサイエンスコーパス: urge incontinence

1 tions, difficulty voiding, and postoperative urge incontinence.

2 g storage symptoms of urgency, frequency and urge incontinence.

3 ptions for treating patients with refractory urge incontinence.

4 ed stress, but a higher proportion developed urge incontinence (15.9% vs. 7.6% at baseline).

5 up and the control group in the frequency of urge incontinence (32.7 percent vs. 38.4 percent, P=0.48

6 was no receipt of drugs or other therapy for urge incontinence and a 70% or greater reduction in freq

7 nation for the paradoxical finding that both urge incontinence and urinary retention are responsive t

8 For classification of urge incontinence and with the extended evaluation as th

9 well, including urinary frequency, urgency, urge incontinence, and pelvic withholding.

10 o the disease process in overactive bladder, urge incontinence, and spinal cord injury.

11 ernative modes of electrical stimulation for urge incontinence are also briefly reviewed.

12 cate lower urinary tract (LUT) dysfunctions (urge incontinence) are found in patients with ALS, which

13 rve stimulation in the treatment of men with urge incontinence, as well as evaluates the financial im

14 ce predicted poorer outcomes in 2 studies of urge incontinence but was not predictive in a study of s

15 Patient's age, improvement of urge incontinence during PNE, and sustained efficacy dur

16 Positive predictors included improvement of urge incontinence episodes during percutaneous nerve eva

17 stress-incontinence episodes (P=0.009), and urge-incontinence episodes (P=0.04).

18 s-incontinence episodes (P=0.02), but not of urge-incontinence episodes (P=0.14).

19 The symptoms of urge incontinence found in the current study are similar

20 However, only pharmacotherapy for urge incontinence has advanced to the level at which sev

21 gram all achieved comparable improvements in urge incontinence in community-dwelling older women.

22 ment predicted better outcomes in 1 study of urge incontinence in women but was unrelated in 4 studie

23 creased frequency, nocturia, with or without urge incontinence; in the absence of proven infection or

24 n-A (100 IU) in patients with non-neurogenic urge incontinence is 33 and 5%, respectively.

25 nce, but its benefit to women with mixed and urge incontinence is well established.

26 symptoms include urinary frequency urgency, urge incontinence, nocturia, dysuria and other kinds of

27 For pharmacotherapy of urge incontinence, older age, female gender, and greater

28 differences between groups in postoperative urge incontinence, satisfaction with the results of the

29 Because treatments differ, urge incontinence should be distinguished from stress in

30 We also assessed postoperative urge incontinence, voiding dysfunction, and adverse even